Results 141 to 150 of about 83,999 (309)
Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography [PDF]
Chang‐Sue Yang+4 more
openalex +1 more source
Breakdown of the blood–brain barrier (BBB) or inner blood–retinal barrier (BRB), induced by pathologically elevated levels of vascular endothelial growth factor (VEGF) or other mediators, can lead to vasogenic edema and significant clinical problems such
E. Bosma+3 more
semanticscholar +1 more source
ABSTRACT Background To evaluate the diagnostic ability of optical coherence tomography (OCT) images to detect posterior pole deformation and anterior displacement of the optic disc (ADOD) in papilledema before and after intracranial pressure reduction with medical treatment.
Gabriel Castilho S. Barbosa+5 more
wiley +1 more source
Subretinal pseudocysts: A novel OCT finding in diabetic macular edema
Purpose: to report the presence of a new structural optical coherence tomography (OCT) finding, namely subretinal pseudocysts, in a patient affected by diabetic retinopathy (DR).
Riccardo Sacconi+5 more
doaj
O edema macular é a principal causa de baixa visual em pacientes diabéticos. Seu mecanismo de formação é complexo e envolve alterações bioquímicas e estruturais.
Mário Martins dos Santos Motta+2 more
doaj +1 more source
Vascular changes in diabetic retinopathy-a longitudinal study in the Nile rat. [PDF]
Diabetic retinopathy is the most common microvascular complication of diabetes and is a major cause of blindness, but an understanding of the pathogenesis of the disease has been hampered by a lack of accurate animal models. Here, we explore the dynamics
Blodi, Barbara A+10 more
core
Fluorescein angiography in laser treatment of diabetic macular edema [PDF]
Tony Realini
openalex +1 more source
Update on corticosteroids for diabetic macular edema
Diabetic macular edema (DME) remains an important cause of visual loss. Although anti-vascular endothelial growth factor (VEGF) agents are generally used as first-line treatments for patients with center-involving DME, there is an important role for corticosteroids as well.
Harry W. Flynn+3 more
openaire +4 more sources
Abstract Aims The LENS trial demonstrated that fenofibrate slowed the progression of diabetic retinopathy compared to placebo in participants with early diabetic eye disease. We assessed its cost‐effectiveness for reducing the progression of diabetic retinopathy versus standard care from a UK National Health Service perspective.
Graham Scotland+166 more
wiley +1 more source
Background:Intravitreal steroid injection is one of the treatment options for diabetic macular edema. Dexamethasone implant is the most novel form of intravitreal steroid therapy.
Fatih Horozoğlu, Özkan Sever
doaj +1 more source